Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
about
In vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in miceMarginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.Targeting of the immune system in systemic lupus erythematosus.Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?Use of antibodies and immunoconjugates for the therapy of more accessible cancers.Why can't we find a new treatment for SLE?An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus.
P2860
Q28752150-48300680-4697-43FA-B1B3-D2C1DCDF941AQ33694922-BE95CC54-6543-4D30-BC04-D545DC5895E0Q37060593-EE1637B3-3779-4160-939E-E6B5B2C1D506Q37120570-22D72A12-FA33-46B3-85E3-3E48C927370EQ37174938-FA46794E-B2BC-43F9-9EBC-2759B49A8072Q37236049-CB8F435E-4F29-4635-A71C-F5F05F3179F9Q37328468-0B1E63BA-01C2-404D-9262-55025CED2AD8
P2860
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
@ast
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
@en
type
label
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
@ast
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
@en
prefLabel
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
@ast
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
@en
P1476
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
@en
P2093
Robert Eisenberg
P304
P356
10.2174/187153006779025757
P577
2006-12-01T00:00:00Z